Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijia Mai

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|March 22, 2024
Analysis of innovative two-stage seamless adaptive design with different endpoints and population shiftWeijia Mai, Shein-Chung Chow
Pharmaceutical Statistics|June 17, 2026
Optimizing Randomization Ratios in Clinical Trials With Survival EndpointsLuoying Yang, Weijia Mai, Yuanyuan Han
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 13, 2026
The Pyruvate Kinase Activator Etavopivat (FT-4202) Limits Pulmonary and Systemic Sequelae of Sepsis in a Mouse LPS ModelYouwei Chen, Hongmei Zhu, Lisheng Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|March 22, 2024
Analysis of innovative two-stage seamless adaptive design with different endpoints and population shiftWeijia Mai, Shein-Chung Chow
Pharmaceutical Statistics|June 17, 2026
Optimizing Randomization Ratios in Clinical Trials With Survival EndpointsLuoying Yang, Weijia Mai, Yuanyuan Han
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 13, 2026
The Pyruvate Kinase Activator Etavopivat (FT-4202) Limits Pulmonary and Systemic Sequelae of Sepsis in a Mouse LPS ModelYouwei Chen, Hongmei Zhu, Lisheng Zhang, et al.
Pageof 1